<?xml version="1.0" encoding="UTF-8"?><urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:news="http://www.google.com/schemas/sitemap-news/0.9"><url><loc>https://vitalspanwire.com/news/oligodendrocyte-nrf2-myelin-cognitive-decline</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-25T16:02:21.071Z</news:publication_date><news:title>Myelin-making cells implicated in age-related cognitive decline</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/mots-c-mitochondrial-peptide-antibacterial-defense</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-25T15:51:09.605Z</news:publication_date><news:title>MOTS-c Study Recasts a Mitochondrial Peptide as Part of the Body’s Antibacterial Defense</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/daf-2-depletion-male-worm-lifespan-sex-differences</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-25T11:02:00.772Z</news:publication_date><news:title>DAF-2 depletion extends male worm lifespan while exposing sex-specific trade-offs</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/mazdutide-us-phase-2-obesity-trial</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-24T21:02:19.723Z</news:publication_date><news:title>Mazdutide reduced weight in U.S. phase 2 trial, with tolerability trade-offs</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/mhra-ngpod-nasogastric-device-withdrawal</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-24T16:01:53.496Z</news:publication_date><news:title>MHRA tells UK providers to stop using NGPod tube-placement devices</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/fitbit-activity-rhythms-phenoage-trajectories</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-24T11:02:40.850Z</news:publication_date><news:title>Fitbit activity rhythms tracked with biological-aging trajectories in All of Us study</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/er-100-rtr242-rls-1496-aging-mechanisms-human-trials</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-23T22:36:49.649Z</news:publication_date><news:title>ER-100, RTR242 and RLS-1496 Put Three Aging Mechanisms Into Early Human Tests</news:title></news:news></url><url><loc>https://vitalspanwire.com/news/enzyme-activated-peptide-prodrug-pseudomonas-biofilms</loc><news:news><news:publication><news:name>Vitalspan Wire</news:name><news:language>en</news:language></news:publication><news:publication_date>2026-08-23T21:03:56.408Z</news:publication_date><news:title>Enzyme-activated peptide prodrug targets Pseudomonas in laboratory biofilms</news:title></news:news></url></urlset>